Yeul Hong Kim

Seoul National University Hospital

South Korea

Research Interests

Explore related searches

Professors in South Korea Professors in Cancer Biology Cancer Biology professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (8)

Year:

2024

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

Jungyoon Choi

Assistant Professor

St. Anne's University Hospital

SOUTH KOREA

View details

Boyeon Kim

Yonsei University College of Medicine

SOUTH KOREA

View details

KYONG HWA PARK

Associate Professor

Seoul National University Hospital

SOUTH KOREA

View details

SUNG YONG LEE

Seoul National University Hospital

SOUTH KOREA

View details

Yu-Wei Chen

Assistant Clinical Professor of Medicine

University of California, San Diego

UNITED STATES

View details

Kye Hwa Lee

Research Associate Professor

Asan Medical Center

SOUTH KOREA

View details

Seung-Yong Jeong

Professor

Seoul National University College of Medicine

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yeul Hong Kim

Research Interests

Explore related searches

Contact this professor

Articles (8)

Large-Scale Cancer Genomic Analysis Reveals Significant Disparities between Microsatellite Instability and Tumor Mutational Burden

Identification of Biomarkers Associated with Liver Metastasis Progression from Colorectal Cancer Using Exosomal RNA Profiling.

Development and Validation of Targeted Gene Sequencing Panel Based Companion Diagnostic for Korean Patients with Solid Tumors.

Clinical Implication of Liquid Biopsy in Colorectal Cancer Patients Treated with Metastasectomy.

Tumor Suppressor miR-584-5p Inhibits Migration and Invasion in Smoking Related Non-Small Cell Lung Cancer Cells by Targeting YKT6.

The Clinical Significance of RAS, PIK3CA, and PTEN Mutations in Non-Small Cell Lung Cancer Using Cell-Free DNA

HSP90 Inhibitor, 17-DMAG, Alone and in Combination with Lapatinib Attenuates Acquired Lapatinib-Resistance in ER-positive, HER2-Overexpressing Breast Cancer Cell Line

Clathrin-mediated EGFR endocytosis as a potential therapeutic strategy for overcoming primary resistance of EGFR TKI in wild-type EGFR non-small cell lung cancer.

Collaborators (7)

Jungyoon Choi

Boyeon Kim

KYONG HWA PARK

SUNG YONG LEE

Yu-Wei Chen

Kye Hwa Lee

Seung-Yong Jeong

Make your next move.